An audit of surgical management of gastrointestinal stromal tumours (GIST)

European Journal of Surgical Oncology

Volumn 32, Issue 3, 2006, Pages 310-314

  Bucher, Pascal ^a   Egger, J F ^a   Gervaz, P ^a   Ris, F ^a   Weintraub, D ^a   Villiger, P ^a   Buhler, L H ^a   Morel, Ph ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Classification; Gastrointestinal stromal tumours (GIST); Human; Imatinib mesylate; Outcomes; Prognostic factors; Proto oncogene protein c kit KIT CD117; Surgery; Survival analysis

Indexed keywords

IMATINIB; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL TUMOR; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL SURGERY; HUMAN; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; METASTASIS; MITOSIS INDEX; MITOSIS RATE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; RETROSPECTIVE STUDY; SMALL INTESTINE TUMOR; STOMACH TUMOR; SURVIVAL TIME; TISSUE NECROSIS; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33645085295     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.11.021     Document Type: Article

References (40)

1. M. Miettinen M. Majidi J. Lasota Pathology and diagnostic criteria of gastrointestinal stromal tumours (GISTs): A review Eur J Cancer 38 Suppl 5 2002 S39-S51
2. C. Corless J. Fletcher M. Heinrich Biology of gastrointestinal stromal tumours J Clin Oncol 22 18 2004 318-325
3. M. Miettinen J. Lasota Gastrointestinal stromal tumours-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis Virchows Arch 438 1 2001 1-12
4. P. Bucher P. Villiger J. Egger L. Buhler P. Morel Management of gastrointestinal stromal tumours: From diagnosis to treatment Swiss Med Wkly 134 11-12 2004 145-153
5. L. Wang H. Vargas S.W. French Cellular origin of gastrointestinal stromal tumours Arch Pathol Lab Med 124 10 2000 1471-1475
6. M. Heinrich B. Rubin B. Longley J. Fletcher Biology and genetic aspects of gastrointestinal stromal tumours: KIT activation and cytogenetic alterations Hum Pathol 33 5 2002 484-495
7. G.D. Demetri M. von Mehren C.D. Blanke A.D. Van den Abbeele B. Eisenberg P.J. Roberts et. al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumours N Engl J Med 347 7 2002 472-480
8. H. Joensuu C. Fletcher S. Dimitrijevic S. Silberman P. Roberts G. Demetri Management of malignant gastrointestinal stromal tumours Lancet Oncol 3 11 2002 655-664
9. J. Verweij P. Casali J. Zalcberg A. Le Cesne P. Reichardt J. Blay et. al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: Randomized trial Lancet 364 9440 2004 1127-1134
10. P. Wu B. Langerman C. Ryan J. Hart S. Swiger M. Posner Surgical treatment of gastrointestinal stromal tumours in the imatinib (STI-571) era Surgery 134 4 2003 656-665
11. P. Roberts B. Eisenberg Clinical presentation of gastrointestinal stromal tumours and treatment of operable disease Eur J Cancer 38 Suppl 5 2002 S37-S38
12. E. Connolly E. Gaffney J. Reynolds Gastrointestinal stromal tumours Br J Surg 90 10 2003 1178-1186
13. R.P. Dematteo M.C. Heinrich W.M. El-Rifai G. Demetri Clinical management of gastrointestinal stromal tumours: Before and after STI-571 Hum Pathol 33 5 2002 466-477
14. C.D. Fletcher J.J. Berman C. Corless F. Gorstein J. Lasota B.J. Longley et. al. Diagnosis of gastrointestinal stromal tumours: A consensus approach Hum Pathol 33 5 2002 459-465
15. M. Miettinen M. Sarlomo-Rikala J. Lasota Gastrointestinal stromal tumours Ann Chir Gynaecol 87 4 1998 278-281
16. S. Silbermann H. Joensuu Overview of issues related to imatinib therapyof advanced gastrointestinal stromal tumours: A discussion among the experts Eur J Cancer 38 Suppl 5 2002 S66-S69
17. P. Bumming J. Andersson J. Meis-Kindblom H. Klingensteirna K. Engstrom U. Stierner et. al. Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: A centre-based study of 17 patients Br J Cancer 89 3 2003 460-464
18. M. Miettinen W. El-Rifai L.H. Sobin J. Lasota Evaluation of malignancy and prognosis of gastrointestinal stromal tumours: A review Hum Pathol 33 5 2002 478-483
19. R.P. Dematteo J.J. Lewis D. Leung S.S. Mudan J.M. Woodruff M.F. Brennan Two hundred gastrointestinal stromal tumours: Recurrence patterns and prognostic factors for survival Ann Surg 231 1 2000 51-58
20. C. Langer B. Gunawan P. Schuler W. Huber L. Fuzesi H. Becker Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours Br J Surg 90 3 2003 332-339
21. T. Lehnert Gastrointestinal sarcoma (GIST)-a review of surgical management Ann Chir Gynaecol 87 4 1998 297-305
22. T. Aparicio V. Boige J. Sabourin P. Crenn M. Ducreux A. Le Cesne et. al. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours Eur J Surg Oncol 30 10 2004 1098-1103
23. P. Bucher S. Taylor P. Villiger P. Morel M. Brundler For small intestinal stromal tumors are there prognostic factors Am J Surg 187 6 2004 761-766
24. T.S. Emory L.H. Sobin L. Lukes D.H. Lee T.J. O'Leary Prognosis of gastrointestinal smooth-muscle (stromal) tumours: Dependence on anatomic site Am J Surg Pathol 23 1 1999 82-87
25. J.P. Pierie U. Choudry A. Muzikansky B.Y. Yeap W.W. Souba M.J. Ott The effect of surgery and grade on outcome of gastrointestinal stromal tumours Arch Surg 136 4 2001 383-389
26. P.R. Verreet T.A. Clausing C. Schoepp Principles of surgical management of stromal tumour Chirurg 71 11 2000 1335-1344
27. B. Eisenberg I. Judson Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy Ann Surg Oncol 11 5 2004 465-475
28. P. Roberts GIST. Gastrointestinal stromal tumours Ann Chir Gynaecol 87 4 1998 277
29. C.R. Rossi S. Mocellin R. Mencarelli M. Foletto P. Pilati D. Nitti et. al. Gastrointestinal stromal tumours: From a surgical to a molecular approach Int J Cancer 107 2 2003 171-176
30. H. Yan P. Marchettini Y.I. Acherman S.A. Gething E. Brun P.H. Sugarbaker Prognostic assessment of gastrointestinal stromal tumour Am J Clin Oncol 26 3 2003 221-228
31. S. Lin M. Huang C. Zeng T. Wang Z. Liu R. Shiay Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumours World Gastroenterol 9 12 2003 2809-2812
32. I. Pidhorecky R.T. Cheney W.G. Kraybill J.F. Gibbs Gastrointestinal stromal tumours: Current diagnosis, biologic behavior, and management Ann Surg Oncol 7 9 2000 705-712
33. L.J. He B.S. Wang C.C. Chen Smooth muscle tumours of the digestive tract: Report of 160 cases Br J Surg 75 2 1988 184-186
34. M. Miettinen M. Sarlomo-Rikala J. Lasota Gastrointestinal stromal tumours: Recent advances in understanding of their biology Hum Pathol 30 10 1999 1213-1220
35. M. Pross T. Manger H.U. Schulz H. Lippert A. Roessner T. Gunther Gastrointestinal stromal tumours-problems in diagnosis and therapy Chirurg 70 7 1999 807-812
36. B. Clary M. Dematteo J. Lewis D. Leung M. Brennan Gastrointestinal stromal tumours and leiomyosarcoma of the abdomen and retroperitoneum: A clinical comparison Ann Surg Oncol 8 4 2001 290-299
37. T. Lehnert M. Schwarzbach F. Willeke C. Herfarth Gastrointestinal stroma tumours-a special entity with unique radicality principles Langenbecks Arch Chir Suppl Kongressbd 115 1998 356-358
38. T.S. Emory T.J. O'Leary Prognosis and surveillance of gastrointestinal stromal/smooth muscle tumours Ann Chir Gynaecol 87 4 1998 306-310
39. L. Samiian M. Weaver V. Velanovich Evaluation of gastrointestinal stromal tumours for recurrence rates and patterns of long-term follow-up Am Surg 70 3 2004 187-192
40. R. DeMatteo The GIST targeted cancer therapy: A tumour (gastrointestinal stromal tumour), a mutated gene (c-kit), and a molecular inhibitor (STI571) Am Surg Oncol 9 9 2002 831-839